Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management
The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4 T-cells producing IFN-γ with a low expression of CD27 have been descri...
Saved in:
Published in | Frontiers in immunology Vol. 9; p. 3094 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
09.01.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1664-3224 1664-3224 |
DOI | 10.3389/fimmu.2018.03094 |
Cover
Abstract | The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4
T-cells producing IFN-γ
with a low expression of CD27 have been described as an active TB marker. In addition, there are unknown homing receptors related to TB, such as CCR4, which might be useful for understanding TB pathogenesis. The aim of our study is focused on the assessment of several T-cell subsets to understand immune-mechanisms in TB. This phenotypic immune characterization is based on the study of the specific immune responses of T-cells expressing CD27 and/or CCR4 homing markers. Subjects enrolled in the study were: (i) 22 adult patients with active TB, and (ii) 26 individuals with latent TB infection (LTBI). Blood samples were drawn from each patient. The expression of CD27 and/or CCR4 markers were analyzed within CD4
T-cells producing: (i) IFN-γ
, (ii) TNF-α
, (iii) TNF-α
IFN-γ
, and (iv) IFN-γ
and/or TNF-α
. The percentage of CD27
within all CD4
T-cell populations analyzed was significantly higher on active TB compared to LTBI after PPD or ESAT-6/CFP-10 stimulation. As previously reported, a ratio based on the CD27 median fluorescence intensity (MFI) was also explored (MFI of CD27 in CD4
T-cells over MFI of CD27 in IFN-γ
CD4
T-cells), being significantly increased during disease (
< 0.0001 after PPD or ESAT-6/CFP-10 stimulation). This ratio was also assessed on the other CD4
T-cells functional profiles after specific stimulation, being significantly associated with active TB. Highest diagnostic accuracies for active TB (AUC ≥ 0.91) were achieved for: (i) CD27 within IFN-γ
TNF-α
CD4
T-cells in response to ESAT-6/CFP-10, (ii) CD27 and CCR4 markers together within IFN-γ
CD4
T-cells in response to PPD, and (iii) CD27 MFI ratio performed on IFN-γ
TNF-α
CD4
T-cells after ESAT-6/CFP-10 stimulation. The lowest diagnostic accuracy was observed when CCR4 marker was evaluated alone (AUC ≤ 0.77). CD27 and CCR4 expression detection could serve as a good method for immunodiagnosis. Moreover, the immunological characterization of markers/subset populations could be a promising tool for understanding the biological basis of the disease. |
---|---|
AbstractList | The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4+ T-cells producing IFN-γ+ with a low expression of CD27 have been described as an active TB marker. In addition, there are unknown homing receptors related to TB, such as CCR4, which might be useful for understanding TB pathogenesis. The aim of our study is focused on the assessment of several T-cell subsets to understand immune-mechanisms in TB. This phenotypic immune characterization is based on the study of the specific immune responses of T-cells expressing CD27 and/or CCR4 homing markers. Subjects enrolled in the study were: (i) 22 adult patients with active TB, and (ii) 26 individuals with latent TB infection (LTBI). Blood samples were drawn from each patient. The expression of CD27 and/or CCR4 markers were analyzed within CD4+ T-cells producing: (i) IFN-γ+, (ii) TNF-α+, (iii) TNF-α+IFN-γ+, and (iv) IFN-γ+ and/or TNF-α+. The percentage of CD27- within all CD4+ T-cell populations analyzed was significantly higher on active TB compared to LTBI after PPD or ESAT-6/CFP-10 stimulation. As previously reported, a ratio based on the CD27 median fluorescence intensity (MFI) was also explored (MFI of CD27 in CD4+ T-cells over MFI of CD27 in IFN-γ+CD4+ T-cells), being significantly increased during disease (p < 0.0001 after PPD or ESAT-6/CFP-10 stimulation). This ratio was also assessed on the other CD4+ T-cells functional profiles after specific stimulation, being significantly associated with active TB. Highest diagnostic accuracies for active TB (AUC ≥ 0.91) were achieved for: (i) CD27 within IFN-γ+TNF-α+CD4+ T-cells in response to ESAT-6/CFP-10, (ii) CD27 and CCR4 markers together within IFN-γ+CD4+ T-cells in response to PPD, and (iii) CD27 MFI ratio performed on IFN-γ+TNF-α+CD4+ T-cells after ESAT-6/CFP-10 stimulation. The lowest diagnostic accuracy was observed when CCR4 marker was evaluated alone (AUC ≤ 0.77). CD27 and CCR4 expression detection could serve as a good method for immunodiagnosis. Moreover, the immunological characterization of markers/subset populations could be a promising tool for understanding the biological basis of the disease.The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4+ T-cells producing IFN-γ+ with a low expression of CD27 have been described as an active TB marker. In addition, there are unknown homing receptors related to TB, such as CCR4, which might be useful for understanding TB pathogenesis. The aim of our study is focused on the assessment of several T-cell subsets to understand immune-mechanisms in TB. This phenotypic immune characterization is based on the study of the specific immune responses of T-cells expressing CD27 and/or CCR4 homing markers. Subjects enrolled in the study were: (i) 22 adult patients with active TB, and (ii) 26 individuals with latent TB infection (LTBI). Blood samples were drawn from each patient. The expression of CD27 and/or CCR4 markers were analyzed within CD4+ T-cells producing: (i) IFN-γ+, (ii) TNF-α+, (iii) TNF-α+IFN-γ+, and (iv) IFN-γ+ and/or TNF-α+. The percentage of CD27- within all CD4+ T-cell populations analyzed was significantly higher on active TB compared to LTBI after PPD or ESAT-6/CFP-10 stimulation. As previously reported, a ratio based on the CD27 median fluorescence intensity (MFI) was also explored (MFI of CD27 in CD4+ T-cells over MFI of CD27 in IFN-γ+CD4+ T-cells), being significantly increased during disease (p < 0.0001 after PPD or ESAT-6/CFP-10 stimulation). This ratio was also assessed on the other CD4+ T-cells functional profiles after specific stimulation, being significantly associated with active TB. Highest diagnostic accuracies for active TB (AUC ≥ 0.91) were achieved for: (i) CD27 within IFN-γ+TNF-α+CD4+ T-cells in response to ESAT-6/CFP-10, (ii) CD27 and CCR4 markers together within IFN-γ+CD4+ T-cells in response to PPD, and (iii) CD27 MFI ratio performed on IFN-γ+TNF-α+CD4+ T-cells after ESAT-6/CFP-10 stimulation. The lowest diagnostic accuracy was observed when CCR4 marker was evaluated alone (AUC ≤ 0.77). CD27 and CCR4 expression detection could serve as a good method for immunodiagnosis. Moreover, the immunological characterization of markers/subset populations could be a promising tool for understanding the biological basis of the disease. The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4 + T-cells producing IFN-γ + with a low expression of CD27 have been described as an active TB marker. In addition, there are unknown homing receptors related to TB, such as CCR4, which might be useful for understanding TB pathogenesis. The aim of our study is focused on the assessment of several T-cell subsets to understand immune-mechanisms in TB. This phenotypic immune characterization is based on the study of the specific immune responses of T-cells expressing CD27 and/or CCR4 homing markers. Subjects enrolled in the study were: (i) 22 adult patients with active TB, and (ii) 26 individuals with latent TB infection (LTBI). Blood samples were drawn from each patient. The expression of CD27 and/or CCR4 markers were analyzed within CD4 + T-cells producing: (i) IFN-γ + , (ii) TNF-α + , (iii) TNF-α + IFN-γ + , and (iv) IFN-γ + and/or TNF-α + . The percentage of CD27 − within all CD4 + T-cell populations analyzed was significantly higher on active TB compared to LTBI after PPD or ESAT-6/CFP-10 stimulation. As previously reported, a ratio based on the CD27 median fluorescence intensity (MFI) was also explored (MFI of CD27 in CD4 + T-cells over MFI of CD27 in IFN-γ + CD4 + T-cells), being significantly increased during disease ( p < 0.0001 after PPD or ESAT-6/CFP-10 stimulation). This ratio was also assessed on the other CD4 + T-cells functional profiles after specific stimulation, being significantly associated with active TB. Highest diagnostic accuracies for active TB (AUC ≥ 0.91) were achieved for: (i) CD27 within IFN-γ + TNF-α + CD4 + T-cells in response to ESAT-6/CFP-10, (ii) CD27 and CCR4 markers together within IFN-γ + CD4 + T-cells in response to PPD, and (iii) CD27 MFI ratio performed on IFN-γ + TNF-α + CD4 + T-cells after ESAT-6/CFP-10 stimulation. The lowest diagnostic accuracy was observed when CCR4 marker was evaluated alone (AUC ≤ 0.77). CD27 and CCR4 expression detection could serve as a good method for immunodiagnosis. Moreover, the immunological characterization of markers/subset populations could be a promising tool for understanding the biological basis of the disease. The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4 T-cells producing IFN-γ with a low expression of CD27 have been described as an active TB marker. In addition, there are unknown homing receptors related to TB, such as CCR4, which might be useful for understanding TB pathogenesis. The aim of our study is focused on the assessment of several T-cell subsets to understand immune-mechanisms in TB. This phenotypic immune characterization is based on the study of the specific immune responses of T-cells expressing CD27 and/or CCR4 homing markers. Subjects enrolled in the study were: (i) 22 adult patients with active TB, and (ii) 26 individuals with latent TB infection (LTBI). Blood samples were drawn from each patient. The expression of CD27 and/or CCR4 markers were analyzed within CD4 T-cells producing: (i) IFN-γ , (ii) TNF-α , (iii) TNF-α IFN-γ , and (iv) IFN-γ and/or TNF-α . The percentage of CD27 within all CD4 T-cell populations analyzed was significantly higher on active TB compared to LTBI after PPD or ESAT-6/CFP-10 stimulation. As previously reported, a ratio based on the CD27 median fluorescence intensity (MFI) was also explored (MFI of CD27 in CD4 T-cells over MFI of CD27 in IFN-γ CD4 T-cells), being significantly increased during disease ( < 0.0001 after PPD or ESAT-6/CFP-10 stimulation). This ratio was also assessed on the other CD4 T-cells functional profiles after specific stimulation, being significantly associated with active TB. Highest diagnostic accuracies for active TB (AUC ≥ 0.91) were achieved for: (i) CD27 within IFN-γ TNF-α CD4 T-cells in response to ESAT-6/CFP-10, (ii) CD27 and CCR4 markers together within IFN-γ CD4 T-cells in response to PPD, and (iii) CD27 MFI ratio performed on IFN-γ TNF-α CD4 T-cells after ESAT-6/CFP-10 stimulation. The lowest diagnostic accuracy was observed when CCR4 marker was evaluated alone (AUC ≤ 0.77). CD27 and CCR4 expression detection could serve as a good method for immunodiagnosis. Moreover, the immunological characterization of markers/subset populations could be a promising tool for understanding the biological basis of the disease. The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4+ T-cells producing IFN-γ+ with a low expression of CD27 have been described as an active TB marker. In addition, there are unknown homing receptors related to TB, such as CCR4, which might be useful for understanding TB pathogenesis. The aim of our study is focused on the assessment of several T-cell subsets to understand immune-mechanisms in TB. This phenotypic immune characterization is based on the study of the specific immune responses of T-cells expressing CD27 and/or CCR4 homing markers. Subjects enrolled in the study were: (i) 22 adult patients with active TB, and (ii) 26 individuals with latent TB infection (LTBI). Blood samples were drawn from each patient. The expression of CD27 and/or CCR4 markers were analyzed within CD4+ T-cells producing: (i) IFN-γ+, (ii) TNF-α+, (iii) TNF-α+IFN-γ+, and (iv) IFN-γ+ and/or TNF-α+. The percentage of CD27− within all CD4+ T-cell populations analyzed was significantly higher on active TB compared to LTBI after PPD or ESAT-6/CFP-10 stimulation. As previously reported, a ratio based on the CD27 median fluorescence intensity (MFI) was also explored (MFI of CD27 in CD4+ T-cells over MFI of CD27 in IFN-γ+CD4+ T-cells), being significantly increased during disease (p < 0.0001 after PPD or ESAT-6/CFP-10 stimulation). This ratio was also assessed on the other CD4+ T-cells functional profiles after specific stimulation, being significantly associated with active TB. Highest diagnostic accuracies for active TB (AUC ≥ 0.91) were achieved for: (i) CD27 within IFN-γ+TNF-α+CD4+ T-cells in response to ESAT-6/CFP-10, (ii) CD27 and CCR4 markers together within IFN-γ+CD4+ T-cells in response to PPD, and (iii) CD27 MFI ratio performed on IFN-γ+TNF-α+CD4+ T-cells after ESAT-6/CFP-10 stimulation. The lowest diagnostic accuracy was observed when CCR4 marker was evaluated alone (AUC ≤ 0.77). CD27 and CCR4 expression detection could serve as a good method for immunodiagnosis. Moreover, the immunological characterization of markers/subset populations could be a promising tool for understanding the biological basis of the disease. |
Author | Villar-Hernández, Raquel Domínguez, Jose Fernández-Sanmartín, Marco A. Millet, Joan-Pau Luque-Chacón, Lydia Molina-Pinargote, Israel Muriel-Moreno, Beatriz Ruiz-Manzano, Juan Lacoma, Alicia Stojanovic, Zoran Vila, Sergi González-Díaz, Yoel D. Souza-Galvão, Maria L. De Sabriá, Josefina Prat, Cristina Latorre, Irene Jiménez-Fuentes, María Á. Centeno, Carmen |
AuthorAffiliation | 1 Servei de Microbiologia, Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol , Barcelona , Spain 5 Unitat de Tuberculosi de Drassanes, Hospital Universitari Vall d'Hebron , Barcelona Spain 8 CIBER de Epidemiología y Salud Pública, CIBERESP, Instituto de Salud Carlos III , Madrid , Spain 4 Plataforma de Citometría, Institut d'Investigació Germans Trias i Pujol , Barcelona , Spain 7 Serveis Clínics, Unitat Clínica de Tractament Directament Observat de la Tuberculosi , Barcelona , Spain 3 Departament de Genètica i Microbiologia, Universitat Autònoma de Barcelona , Barcelona , Spain 9 Servei de Pneumologia, Hospital Sant Joan Despí Moises Broggi, Sant Joan Despí , Barcelona , Spain 6 Servei de Pneumologia, Hospital Universitari Germans Trias i Pujol , Barcelona , Spain 2 CIBER Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III , Madrid , Spain |
AuthorAffiliation_xml | – name: 8 CIBER de Epidemiología y Salud Pública, CIBERESP, Instituto de Salud Carlos III , Madrid , Spain – name: 3 Departament de Genètica i Microbiologia, Universitat Autònoma de Barcelona , Barcelona , Spain – name: 1 Servei de Microbiologia, Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol , Barcelona , Spain – name: 4 Plataforma de Citometría, Institut d'Investigació Germans Trias i Pujol , Barcelona , Spain – name: 6 Servei de Pneumologia, Hospital Universitari Germans Trias i Pujol , Barcelona , Spain – name: 5 Unitat de Tuberculosi de Drassanes, Hospital Universitari Vall d'Hebron , Barcelona Spain – name: 7 Serveis Clínics, Unitat Clínica de Tractament Directament Observat de la Tuberculosi , Barcelona , Spain – name: 9 Servei de Pneumologia, Hospital Sant Joan Despí Moises Broggi, Sant Joan Despí , Barcelona , Spain – name: 2 CIBER Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III , Madrid , Spain |
Author_xml | – sequence: 1 givenname: Irene surname: Latorre fullname: Latorre, Irene – sequence: 2 givenname: Marco A. surname: Fernández-Sanmartín fullname: Fernández-Sanmartín, Marco A. – sequence: 3 givenname: Beatriz surname: Muriel-Moreno fullname: Muriel-Moreno, Beatriz – sequence: 4 givenname: Raquel surname: Villar-Hernández fullname: Villar-Hernández, Raquel – sequence: 5 givenname: Sergi surname: Vila fullname: Vila, Sergi – sequence: 6 givenname: Maria L. De surname: Souza-Galvão fullname: Souza-Galvão, Maria L. De – sequence: 7 givenname: Zoran surname: Stojanovic fullname: Stojanovic, Zoran – sequence: 8 givenname: María Á. surname: Jiménez-Fuentes fullname: Jiménez-Fuentes, María Á. – sequence: 9 givenname: Carmen surname: Centeno fullname: Centeno, Carmen – sequence: 10 givenname: Juan surname: Ruiz-Manzano fullname: Ruiz-Manzano, Juan – sequence: 11 givenname: Joan-Pau surname: Millet fullname: Millet, Joan-Pau – sequence: 12 givenname: Israel surname: Molina-Pinargote fullname: Molina-Pinargote, Israel – sequence: 13 givenname: Yoel D. surname: González-Díaz fullname: González-Díaz, Yoel D. – sequence: 14 givenname: Alicia surname: Lacoma fullname: Lacoma, Alicia – sequence: 15 givenname: Lydia surname: Luque-Chacón fullname: Luque-Chacón, Lydia – sequence: 16 givenname: Josefina surname: Sabriá fullname: Sabriá, Josefina – sequence: 17 givenname: Cristina surname: Prat fullname: Prat, Cristina – sequence: 18 givenname: Jose surname: Domínguez fullname: Domínguez, Jose |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30687314$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Uk1v1DAQtVARLaV3TshHJJTF304uSFXKx0qLkOhythzveHFJ4sVOKvXf490tVYuEL2OP33szHr-X6GSMIyD0mpIF53Xz3odhmBeM0HpBOGnEM3RGlRIVZ0ycPNqfooucb0hZouGcyxfolBNVa07FGZqvp3lzh6PH7RXT2I4b3LbfBf5q0y9IGccRX-_ABR9cQYh3eF210PcZ24yXpf4IeB1jOfuY8KWbwi0cRFZ2gnHC67mD5OY-5pCL5mi3MJT8K_Tc2z7DxX08Rz8-fVy3X6rVt8_L9nJVOaHYVGnBatbxuq5LpNRJ0akOKIhGqaaTDjQlCjz4xlGwtVJS6k5wrjXXwJji52h51N1Ee2N2KQw23ZlogzkkYtoam6bgejCiTMRr6JhSRMiONRtvBW2I7CSRivqi9eGotZu7ATauPCPZ_ono05sx_DTbeGsU50LofTNv7wVS_D1DnswQsivDtCPEORtGdSOokpoV6JvHtR6K_P23AiBHgEsx5wT-AUKJ2bvDHNxh9u4wB3cUivqH4sJkpxD33Yb-_8Q_e8G82g |
CitedBy_id | crossref_primary_10_3389_fmicb_2021_745592 crossref_primary_10_3390_pathogens11091034 crossref_primary_10_1016_j_jinf_2020_03_064 crossref_primary_10_4081_monaldi_2024_2984 crossref_primary_10_1093_cid_ciab144 crossref_primary_10_1038_s41598_020_70204_w crossref_primary_10_3390_jcm11072000 crossref_primary_10_1186_s12865_021_00430_y crossref_primary_10_3389_fimmu_2020_00127 crossref_primary_10_3390_pathogens9030180 crossref_primary_10_3389_fimmu_2020_02006 crossref_primary_10_1111_imr_12963 crossref_primary_10_3389_fimmu_2021_662128 crossref_primary_10_1016_j_tube_2022_102221 crossref_primary_10_3390_jcm12196398 crossref_primary_10_3389_fimmu_2021_721013 crossref_primary_10_1016_j_jctube_2021_100275 crossref_primary_10_3389_fimmu_2022_853572 crossref_primary_10_3389_fmicb_2022_885312 crossref_primary_10_1186_s12879_022_07895_1 crossref_primary_10_1186_s40001_024_01713_x crossref_primary_10_1016_j_micinf_2019_07_003 crossref_primary_10_1038_s41392_022_01136_2 |
Cites_doi | 10.1016/j.jinf.2016.09.008 10.1084/jem.20100090 10.1128/CVI.00364-07 10.1038/nm.2299 10.1007/s00281-015-0490-8 10.1038/nrmicro2236 10.1111/resp.13272 10.1157/13126836 10.1093/infdis/jit265 10.1016/S0140-6736(00)02742-2 10.3389/fimmu.2017.00968 10.1183/09031936.00114810 10.1002/eji.201243262 10.1086/592448 10.1038/nri3537 10.1007/s10875-010-9418-1 10.1016/j.jinf.2015.07.009 10.4049/jimmunol.178.2.976 10.1183/09031936.00196608 10.1183/13993003.00153-2018 10.3389/fimmu.2017.01948 10.1183/13993003.01012-2016 10.1038/nri2960 10.1084/jem.20130091 10.1371/journal.pone.0043733 10.1016/S1473-3099(14)70884-9 10.1016/j.cytogfr.2012.10.002 10.3389/fmicb.2014.00517 10.1016/S0140-6736(06)68579-6 10.1016/S1579-2129(10)70061-6 10.1007/978-1-4614-6111-1_8 10.1016/j.diagmicrobio.2009.07.015 10.1371/journal.pone.0000735 10.1093/infdis/jix107 |
ContentType | Journal Article |
Copyright | Copyright © 2019 Latorre, Fernández-Sanmartín, Muriel-Moreno, Villar-Hernández, Vila, Souza-Galvão, Stojanovic, Jiménez-Fuentes, Centeno, Ruiz-Manzano, Millet, Molina-Pinargote, González-Díaz, Lacoma, Luque-Chacón, Sabriá, Prat and Domínguez. 2019 Latorre, Fernández-Sanmartín, Muriel-Moreno, Villar-Hernández, Vila, Souza-Galvão, Stojanovic, Jiménez-Fuentes, Centeno, Ruiz-Manzano, Millet, Molina-Pinargote, González-Díaz, Lacoma, Luque-Chacón, Sabriá, Prat and Domínguez |
Copyright_xml | – notice: Copyright © 2019 Latorre, Fernández-Sanmartín, Muriel-Moreno, Villar-Hernández, Vila, Souza-Galvão, Stojanovic, Jiménez-Fuentes, Centeno, Ruiz-Manzano, Millet, Molina-Pinargote, González-Díaz, Lacoma, Luque-Chacón, Sabriá, Prat and Domínguez. 2019 Latorre, Fernández-Sanmartín, Muriel-Moreno, Villar-Hernández, Vila, Souza-Galvão, Stojanovic, Jiménez-Fuentes, Centeno, Ruiz-Manzano, Millet, Molina-Pinargote, González-Díaz, Lacoma, Luque-Chacón, Sabriá, Prat and Domínguez |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3389/fimmu.2018.03094 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
ExternalDocumentID | oai_doaj_org_article_4687f7eb266045b29dfa41905b50561f PMC6334476 30687314 10_3389_fimmu_2018_03094 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM CGR CUY CVF ECM EIF IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-74282b388828211c54b6be1e49669b5ce7106efef9c1ea866557b4337737e2263 |
IEDL.DBID | DOA |
ISSN | 1664-3224 |
IngestDate | Wed Aug 27 01:15:35 EDT 2025 Thu Aug 21 18:33:12 EDT 2025 Fri Sep 05 11:27:47 EDT 2025 Thu Jan 02 22:59:25 EST 2025 Tue Jul 01 01:35:40 EDT 2025 Thu Apr 24 23:05:00 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | tuberculosis CD27 CD4 T-cells flow cytometry immunity latent tuberculosis CCR4 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-74282b388828211c54b6be1e49669b5ce7106efef9c1ea866557b4337737e2263 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology Edited by: Jesús Gonzalo-Asensio, Universidad de Zaragoza, Spain Reviewed by: Damien Portevin, Swiss Tropical and Public Health Institute, Switzerland; Paul Fisch, University Hospital Freiburg, Germany These authors have contributed equally to this work and as co-senior authorship |
OpenAccessLink | https://doaj.org/article/4687f7eb266045b29dfa41905b50561f |
PMID | 30687314 |
PQID | 2179416572 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4687f7eb266045b29dfa41905b50561f pubmedcentral_primary_oai_pubmedcentral_nih_gov_6334476 proquest_miscellaneous_2179416572 pubmed_primary_30687314 crossref_primary_10_3389_fimmu_2018_03094 crossref_citationtrail_10_3389_fimmu_2018_03094 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-01-09 |
PublicationDateYYYYMMDD | 2019-01-09 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-09 day: 09 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2019 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Latorre (B11) 2009; 65 Streitz (B13) 2007; 2 Ferrara (B6) 2006; 367 Goletti (B2) 2018; 23 Petruccioli (B17) 2015; 71 Harari (B23) 2011; 17 Jiang (B12) 2010; 30 Portevin (B16) 2014; 14 Nikitina (B14) 2012; 7 Mikhak (B19) 2013; 210 Riou (B31) 2017; 8 Andersen (B9) 2000; 356 Rozot (B26) 2013; 43 Behar (B28) 2013; 783 Ruiz-Manzano (B22) 2008; 44 Petruccioli (B29) 2016; 73 Sester (B10) 2011; 37 Latorre (B8) 2010; 35 Geldmacher (B15) 2010; 207 Serra-Vidal (B3) 2014; 5 Bordon (B20) 2013; 13 Lin (B27) 2015; 37 Pollock (B24) 2013; 208 Gonzalez-Martin (B21) 2010; 46 Kapina (B32) 2007; 178 Qiu (B33) 2008; 198 Petruccioli (B1) 2016; 48 Walzl (B5) 2011; 11 Dominguez (B7) 2008; 15 Slight (B18) 2013; 24 Barry (B4) 2009; 7 Halliday (B25) 2017; 215 Musvosvi (B30) 2018; 51 Bastos (B34) 2017; 8 |
References_xml | – volume: 73 start-page: 588 year: 2016 ident: B29 article-title: First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus publication-title: J Infect doi: 10.1016/j.jinf.2016.09.008 – volume: 207 start-page: 2869 year: 2010 ident: B15 article-title: Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection publication-title: J Exp Med. doi: 10.1084/jem.20100090 – volume: 15 start-page: 168 year: 2008 ident: B7 article-title: Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00364-07 – volume: 17 start-page: 37 year: 2011 ident: B23 article-title: Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease publication-title: Nat Med doi: 10.1038/nm.2299 – volume: 37 start-page: 239 year: 2015 ident: B27 article-title: CD8 T cells and Mycobacterium tuberculosis infection publication-title: Semin Immunopathol doi: 10.1007/s00281-015-0490-8 – volume: 7 start-page: 845 year: 2009 ident: B4 article-title: The spectrum of latent tuberculosis: rethinking the biology and intervention strategies publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro2236 – volume: 23 start-page: 455 year: 2018 ident: B2 article-title: Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease publication-title: Respirology doi: 10.1111/resp.13272 – volume: 44 start-page: 551 year: 2008 ident: B22 article-title: Diagnosis and treatment of tuberculosis publication-title: Arch Bronconeumol doi: 10.1157/13126836 – volume: 208 start-page: 952 year: 2013 ident: B24 article-title: T-cell immunophenotyping distinguishes active from latent tuberculosis publication-title: J Infect Dis doi: 10.1093/infdis/jit265 – volume: 356 start-page: 1099 year: 2000 ident: B9 article-title: Specific immune-based diagnosis of tuberculosis publication-title: Lancet doi: 10.1016/S0140-6736(00)02742-2 – volume: 8 start-page: 968 year: 2017 ident: B31 article-title: Analysis of the phenotype of Mycobacterium tuberculosis-specific CD4+ T cells to discriminate latent from active tuberculosis in HIV-uninfected and HIV-infected individuals publication-title: Front Immunol doi: 10.3389/fimmu.2017.00968 – volume: 37 start-page: 100 year: 2011 ident: B10 article-title: Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis publication-title: Eur Respir J doi: 10.1183/09031936.00114810 – volume: 43 start-page: 1568 year: 2013 ident: B26 article-title: Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease publication-title: Eur J Immunol doi: 10.1002/eji.201243262 – volume: 198 start-page: 1514 year: 2008 ident: B33 article-title: Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses publication-title: J Infect Dis doi: 10.1086/592448 – volume: 13 start-page: 705 year: 2013 ident: B20 article-title: Mucosal immunology: air miles for T cells publication-title: Nat Rev Immunol doi: 10.1038/nri3537 – volume: 30 start-page: 566 year: 2010 ident: B12 article-title: Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis publication-title: J Clin Immunol doi: 10.1007/s10875-010-9418-1 – volume: 71 start-page: 526 year: 2015 ident: B17 article-title: Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis publication-title: J Infect doi: 10.1016/j.jinf.2015.07.009 – volume: 178 start-page: 976 year: 2007 ident: B32 article-title: CD27low CD4 T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27high precursors in situ, produce IFN-gamma, and protect the host against tuberculosis infection publication-title: J Immunol doi: 10.4049/jimmunol.178.2.976 – volume: 35 start-page: 338 year: 2010 ident: B8 article-title: Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis publication-title: Eur Respir J doi: 10.1183/09031936.00196608 – volume: 51 start-page: 1800153 year: 2018 ident: B30 article-title: T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation publication-title: Eur Respir J doi: 10.1183/13993003.00153-2018 – volume: 8 start-page: 1948 year: 2017 ident: B34 article-title: The troika host-pathogen-extrinsic factors in tuberculosis: modulating inflammation and clinical outcomes publication-title: Front Immunol doi: 10.3389/fimmu.2017.01948 – volume: 48 start-page: 175 year: 2016 ident: B1 article-title: Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis publication-title: Eur Respir J doi: 10.1183/13993003.01012-2016 – volume: 11 start-page: 343 year: 2011 ident: B5 article-title: Immunological biomarkers of tuberculosis publication-title: Nat Rev Immunol doi: 10.1038/nri2960 – volume: 210 start-page: 1855 year: 2013 ident: B19 article-title: Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4 publication-title: J Exp Med doi: 10.1084/jem.20130091 – volume: 7 start-page: e43733 year: 2012 ident: B14 article-title: Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans publication-title: PLoS ONE doi: 10.1371/journal.pone.0043733 – volume: 14 start-page: 931 year: 2014 ident: B16 article-title: Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(14)70884-9 – volume: 24 start-page: 105 year: 2013 ident: B18 article-title: Chemokines shape the immune responses to tuberculosis publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2012.10.002 – volume: 5 start-page: 517 year: 2014 ident: B3 article-title: Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis publication-title: Front Microbiol doi: 10.3389/fmicb.2014.00517 – volume: 367 start-page: 1328 year: 2006 ident: B6 article-title: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study publication-title: Lancet doi: 10.1016/S0140-6736(06)68579-6 – volume: 46 start-page: 255 year: 2010 ident: B21 article-title: Consensus document on the diagnosis, treatment and prevention of tuberculosis publication-title: Arch Bronconeumol doi: 10.1016/S1579-2129(10)70061-6 – volume: 783 start-page: 141 year: 2013 ident: B28 article-title: Antigen-specific CD8(+) T cells and protective immunity to tuberculosis publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4614-6111-1_8 – volume: 65 start-page: 236 year: 2009 ident: B11 article-title: Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2009.07.015 – volume: 2 start-page: e735 year: 2007 ident: B13 article-title: Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis publication-title: PLoS ONE doi: 10.1371/journal.pone.0000735 – volume: 215 start-page: 1480 year: 2017 ident: B25 article-title: Stratification of latent Mycobacterium tuberculosis infection by cellular immune profiling publication-title: J Infect Dis doi: 10.1093/infdis/jix107 |
SSID | ssj0000493335 |
Score | 2.3418972 |
Snippet | The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management,... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 3094 |
SubjectTerms | Adult Biomarkers CCR4 CD27 CD4 T-cells CD4-Positive T-Lymphocytes - immunology CD4-Positive T-Lymphocytes - metabolism CD8-Positive T-Lymphocytes - metabolism Cytokines - metabolism Female flow cytometry Host-Pathogen Interactions - immunology Humans immunity Immunology Immunophenotyping latent tuberculosis Latent Tuberculosis - immunology Latent Tuberculosis - microbiology Latent Tuberculosis - therapy Leukocytes, Mononuclear - immunology Leukocytes, Mononuclear - metabolism Male Middle Aged Mycobacterium tuberculosis - immunology Receptors, CCR4 - metabolism ROC Curve T-Cell Antigen Receptor Specificity - immunology Tuberculosis - immunology Tuberculosis - microbiology Tuberculosis - therapy Tumor Necrosis Factor Receptor Superfamily, Member 7 - metabolism Young Adult |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagCIkL4s3ykpG4IJR2_YgdHxAqgaog4IB2pd4iOxmXRWnSbjYS--8ZO-mWRStOnKIkdjLyeDLfF49nCHlly6lHx8GSVHtIZAY8MZ4jcbUW4bJhrnIx2uKbOp7LzyfpydX26HEAu53ULtSTmi_r_V8X63do8G8D40R_e-AXZ2d9iNLK9sOCgbxObqBf4mGOfx3B_s8BCwsh0mGtcmfHLd8UU_jvwp1_h0_-4Y-O7pDbI5Ckh4Pm75Jr0NwjN4fSkuv7pA8Bgmvaepp_4JrapqJ5_l3SsDcHER9tGxpLz_tFiS3kGzpLcqjrjtqOfgp7RoDO2hbPEdTSw_hRjA_5gti0WdFZ72BZ9nXbLTp6FULzgMyPPs7y42QssZCUUvFVgsQ4404gDcYjY2UqnXLAQCILMi4tAQGIAg_elAxsyI2XaieF0FpoQOQmHpK9pm3gMaFgjSoRDSJjtHIK2lSGQeb0VHtdcUgn5OBycItyzD8eymDUBfKQoI4iqqMI6iiiOibk9abH-ZB74x9t3wd9bdqFrNnxQrs8LUYjLKTKUBhwCEoQyTpuKm8lIqLUBRzI_IS8vNR2gVYWlk5sA23fFTx8t5hKNZ-QR4P2N69C0pVpwVAEvTUvtmTZvtMsfsRM3kqEhIvqyf8Q_im5hcNh4u8h84zsrZY9PEfAtHIvoh38BmZ_Ejw priority: 102 providerName: Scholars Portal |
Title | Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30687314 https://www.proquest.com/docview/2179416572 https://pubmed.ncbi.nlm.nih.gov/PMC6334476 https://doaj.org/article/4687f7eb266045b29dfa41905b50561f |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: KQ8 dateStart: 20100101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: GX1 dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: RPM dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1664-3224 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: M48 dateStart: 20101001 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQpUpcELQ8lpeMxAWhsOt3fCyhpSDggLbS3iw7GYtF2wQ1m0P_PWNnu-wiBBcujpI4ieUZe74vHs8Q8tLXs4iGgxXKRChkCbywkSNx9R7hsmWhCdnb4os-v5AfF2qxk-or-YSN4YHHjptKXZpokP9pjegjcNtEL9GKqZBsN4tp9kUztkOmvo-4VwihxnVJZGF2GpeXl0Ny5SrfpFUFuWeHcrj-P2HM310ld2zP2V1yZwMa6cnY2HvkFrRH5HBMI3l9TIbkDHhNu0ird9xQ3za0qr5KmvbhILqjXUtzmvm4rLGGfE3nRQWrVU99Tz-k_SFA512H5whg6UmeAPNLPiEObdd0PgS4qodV1y97-std5j65ODudV-fFJp1CUUvN1wWS4JIHgZQXj4zVSgYdgIFExmODqgHBhoYI0dYMfIqDp0yQQhgjDCBKEw_IQdu18IhQ8FbXiPyQHXo5A2Mby6AMZoaiajioCZnedK6rN7HGU8qLlUPOkcThsjhcEofL4piQV9snfoxxNv5S922S17ZeipCdL6DeuI3euH_pzYS8uJG2wxGVlkl8C93QO57mKKaV4RPycJT-9lNIsEojGDbB7OnFXlv277TLbzlqtxYpuKJ-_D8a_4Tcxu6w-VeQfUoO1lcDPENwtA7P8zjA8v2CYflZlj8Bi1MLVw |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Study+of+CD27+and+CCR4+Markers+on+Specific+CD4%2B+T-Cells+as+Immune+Tools+for+Active+and+Latent+Tuberculosis+Management&rft.jtitle=Frontiers+in+immunology&rft.au=Irene+Latorre&rft.au=Irene+Latorre&rft.au=Irene+Latorre&rft.au=Marco+A.+Fern%C3%A1ndez-Sanmart%C3%ADn&rft.date=2019-01-09&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=9&rft_id=info:doi/10.3389%2Ffimmu.2018.03094&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_4687f7eb266045b29dfa41905b50561f |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |